The most suitable approach as an analytical alternative methodology for the detection of trace clinical analytes is based on affinity sensing, in which the immobilized biological element (receptor) can be an antibody, a receptor (natural or synthetic), a nucleic acid, or an aptamer.
Immunosensors, based on antibody–antigen interactions, and DNA‐based sensing, based on nucleic acid hybridization, are first reported. Finally an aptasensor, based on a new category of relevant receptors, nucleic acid sequences selected in vitro named aptamers, is shown. The reported examples deal with two different transduction principles, electrochemical and piezoelectric, applied to analyte detection of clinical interest. The development of immunosensors for progesterone detection by electrochemical sensing is first reported. Then DNA‐based sensing, for point mutation detection in the b‐globin gene, occurring in b‐thalassemia, is shown. Finally aptasensing for thrombin detection is discussed.
Both single‐use and multiuse sensing have been shown to be suitable for trace analysis in clinical chemistry. Both approaches possess sensitivity, reproducibility, and analysis times compatible with the final application.